Free Trial

Tyra Biosciences (TYRA) Short Interest Ratio & Short Volume

Tyra Biosciences logo
$9.76 -0.22 (-2.20%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$9.74 -0.02 (-0.20%)
As of 05/21/2025 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tyra Biosciences Short Interest Data

Tyra Biosciences (TYRA) has a short interest of 4.35 million shares, representing 13.52% of the float (the number of shares available for trading by the public). This marks a 10.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 13.3, indicating that it would take 13.3 days of the average trading volume of 263,010 shares to cover all short positions.

Current Short Interest
4,350,000 shares
Previous Short Interest
3,940,000 shares
Change Vs. Previous Month
+10.41%
Dollar Volume Sold Short
$44.81 million
Short Interest Ratio
13.3 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
53,090,000 shares
Float Size
32,170,000 shares
Short Percent of Float
13.52%
Today's Trading Volume
375,056 shares
Average Trading Volume
263,010 shares
Today's Volume Vs. Average
143%
Short Selling Tyra Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Tyra Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TYRA Short Interest Over Time

TYRA Days to Cover Over Time

TYRA Percentage of Float Shorted Over Time

Tyra Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20254,350,000 shares $44.81 million +10.4%13.5%13.3 $10.30
4/15/20253,940,000 shares $34.12 million +5.1%12.8%12.8 $8.66
3/31/20253,750,000 shares $34.88 million -4.3%12.2%11.8 $9.30
3/15/20253,920,000 shares $45.08 million -3.9%12.2%14.1 $11.50
2/28/20254,080,000 shares $47.78 million +10.9%12.7%15.7 $11.71
2/15/20253,680,000 shares $48.54 million +30.5%11.9%15.7 $13.19
1/31/20252,820,000 shares $40.78 million +1.8%9.2%11 $14.46
1/15/20252,770,000 shares $46.34 million +9.1%9.0%8 $16.73
12/31/20242,540,000 shares $35.31 million +0.4%8.3%7.4 $13.90
12/15/20242,530,000 shares $37.80 million +25.9%8.2%7.7 $14.94
11/30/20242,010,000 shares $31.52 million +7.5%6.8%6.1 $15.68
11/15/20241,870,000 shares $28.78 million +6.3%6.3%5.9 $15.39
10/31/20241,760,000 shares $29.36 million -20.0%6.1%6 $16.68
10/15/20242,200,000 shares $53.81 million -7.6%8.3%12 $24.46
9/30/20242,380,000 shares $55.95 million -0.8%8.9%15.4 $23.51
9/15/20242,400,000 shares $50.98 million +6.2%9.0%13.8 $21.24
8/31/20242,260,000 shares $51.44 million +2.3%8.5%13.8 $22.76
8/15/20242,210,000 shares $48.62 million -0.5%8.4%13 $22.00
7/31/20242,220,000 shares $49.20 million +0.5%8.3%13.5 $22.16
7/15/20242,210,000 shares $44.35 million +12.2%8.3%14.4 $20.07
6/30/20241,970,000 shares $31.50 million +3.8%7.4%12.6 $15.99
6/15/20241,897,500 shares $36.89 million -3.2%7.1%13.2 $19.44
5/31/20241,960,000 shares $31.79 million -4.4%7.4%13.2 $16.22
5/15/20242,050,000 shares $37.80 million -40.4%7.7%15.7 $18.44
4/30/20243,440,000 shares $58.82 million +5.2%11.0%26.5 $17.10
4/15/20243,270,000 shares $48.23 million +15.6%13.8%23.4 $14.75
3/31/20242,830,000 shares $46.41 million +8.9%14.9%21 $16.40
3/15/20242,600,000 shares $45.50 million +7.4%13.9%20.6 $17.50
2/29/20242,420,000 shares $48.38 million +6.6%13.0%21.4 $19.99
2/15/20242,270,000 shares $43.13 million +11.3%12.2%21.4 $19.00
1/31/20242,040,000 shares $27.34 million +8.5%10.8%20.4 $13.40
1/15/20241,880,000 shares $24.08 million +30.6%10.1%23.4 $12.81
12/31/20231,440,000 shares $19.94 million -7.1%N/A18.1 $13.85
12/15/20231,550,000 shares $20.93 million -7.2%8.4%20.1 $13.50
11/30/20231,670,000 shares $19.56 million +0.6%9.1%26.4 $11.71
11/15/20231,660,000 shares $20.53 million -6.7%9.0%26.9 $12.37
10/31/20231,780,000 shares $20.65 million +6.6%9.5%29.9 $11.60
10/15/20231,670,000 shares $23.61 million -6.2%8.9%30.5 $14.14
9/30/20231,780,000 shares $24.51 million -4.3%9.5%34.8 $13.77
9/15/20231,860,000 shares $27.36 million +3.3%9.9%29.3 $14.71
The DOJ Just Said Your Money Isn’t Yours (Ad)

What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.

Get your free guide now by clicking here >>
8/31/20231,800,000 shares $27.41 million +1.1%9.7%22.9 $15.23
8/15/20231,780,000 shares $27.59 million +6.0%9.6%22.7 $15.50
7/31/20231,680,000 shares $24.90 million +5.0%9.3%22.1 $14.82
7/15/20231,600,000 shares $23.39 million +1.3%8.9%22.4 $14.62
6/30/20231,580,000 shares $26.91 million +9.0%8.8%23.8 $17.03
6/15/20231,450,000 shares $23.20 million -1.4%8.1%28 $16.00
5/31/20231,470,000 shares $21.27 million +2.8%8.3%47 $14.47
5/15/20231,430,000 shares $18.85 million -0.7%8.0%41.7 $13.18
4/30/20231,440,000 shares $20.40 million +0.7%8.0%28.4 $14.17
4/15/20231,430,000 shares $21.08 million +3.6%8.0%27.1 $14.74
3/31/20231,380,000 shares $22.18 million +7.0%7.8%26.1 $16.07
3/15/20231,290,000 shares $18.33 million +6.6%6.6%25.3 $14.21
2/28/20231,210,000 shares $15.98 million No Change6.2%24.2 $13.21
2/15/20231,210,000 shares $15.10 million -0.8%6.2%21.5 $12.48
1/31/20231,220,000 shares $12.96 million No Change6.2%26.9 $10.62
1/15/20231,220,000 shares $10.24 million -3.9%6.2%26.6 $8.39
12/30/20221,270,000 shares $9.65 million -14.8%6.5%26.5 $7.60
12/15/20221,490,000 shares $9.42 million -2.6%7.6%28.8 $6.32
11/30/20221,530,000 shares $10.73 million -1.3%7.9%31 $7.01
11/15/20221,550,000 shares $11.61 million -6.1%8.0%29.1 $7.49
10/31/20221,650,000 shares $11.42 million -2.4%8.5%39 $6.92
10/15/20221,690,000 shares $11.37 million -2.3%8.8%43.1 $6.73
9/30/20221,730,000 shares $15.21 million +1.2%9.0%41.7 $8.79
9/15/20221,710,000 shares $15.41 million -0.6%8.9%33.8 $9.01
8/31/20221,720,000 shares $11.37 million -8.5%8.9%32.3 $6.61
8/15/20221,880,000 shares $22.47 million -1.6%9.7%33.4 $11.95
7/31/20221,910,000 shares $20.34 million No Change9.8%32.8 $10.65
7/15/20221,910,000 shares $18.43 million -1.6%9.8%29.6 $9.65
6/30/20221,940,000 shares $13.87 million -1.0%10.0%28.9 $7.15
6/15/20221,960,000 shares $11.52 million +1.6%10.1%28.1 $5.88
5/31/20221,930,000 shares $13.18 million -2.5%9.9%23.1 $6.83
5/15/20221,980,000 shares $15.33 million -4.8%10.2%21.2 $7.74
4/30/20222,080,000 shares $15.54 million -8.0%10.6%21.1 $7.47
4/15/20222,260,000 shares $22.33 million -0.9%11.6%20.7 $9.88
3/31/20222,280,000 shares $24.40 million -2.6%11.8%19.8 $10.70
3/15/20222,340,000 shares $23.47 million +15.8%12.2%16.8 $10.03
2/28/20222,020,000 shares $23.94 million +6.3%10.5%10.6 $11.85
2/15/20221,900,000 shares $23.88 million -2.1%9.9%9.8 $12.57
1/31/20221,940,000 shares $25.43 million +7.2%10.3%9.9 $13.11
1/15/20221,810,000 shares $22.55 million +5.2%9.6%9 $12.46
12/31/20211,720,000 shares $24.20 million No Change9.1%8.3 $14.07

TYRA Short Interest - Frequently Asked Questions

What is Tyra Biosciences' current short interest?

Short interest is the volume of Tyra Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 4,350,000 shares of TYRA short. 13.52% of Tyra Biosciences' shares are currently sold short. Learn More on Tyra Biosciences' current short interest.

What is a good short interest ratio for Tyra Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TYRA shares currently have a short interest ratio of 13.0. Learn More on Tyra Biosciences's short interest ratio.

What is a good short interest percentage for Tyra Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.52% of Tyra Biosciences' floating shares are currently sold short.

Is Tyra Biosciences' short interest increasing or decreasing?

Tyra Biosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 4,350,000 shares, an increase of 10.4% from the previous total of 3,940,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Tyra Biosciences' float size?

Tyra Biosciences currently has issued a total of 53,090,000 shares. Some of Tyra Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tyra Biosciences currently has a public float of 32,170,000 shares.

How does Tyra Biosciences' short interest compare to its competitors?

13.52% of Tyra Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tyra Biosciences: Vericel Co. (9.18%), NewAmsterdam Pharma (8.68%), Kymera Therapeutics, Inc. (11.03%), Biohaven Ltd. (7.65%), Denali Therapeutics Inc. (9.34%), ImmunityBio, Inc. (7.79%), Harmony Biosciences Holdings, Inc. (7.46%), Twist Bioscience Co. (16.62%), Belite Bio, Inc (0.23%), Kiniksa Pharmaceuticals, Ltd. (4.56%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Tyra Biosciences stock?

Short selling TYRA is an investing strategy that aims to generate trading profit from Tyra Biosciences as its price is falling. TYRA shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Tyra Biosciences?

A short squeeze for Tyra Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TYRA, which in turn drives the price of the stock up even further.

How often is Tyra Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TYRA, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:TYRA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners